Jacobs Levy Equity Management
FCSC

Jacobs Levy Equity Management’s Fibrocell Science Inc. FCSC Stock Holding History

Jacobs Levy Equity Management’s Portfolio FCSC Stock Details FCSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-6,448
Closed -$64K – 1059
2017
Q1 		$64K Buy
+6,448
New +$71.5K ﹤0.01% 885
2016
Q4 		– Sell
-5,629
Closed -$61K – 1106
2016
Q3 		$61K Sell
5,629
-6,558
-54% -$97.3K ﹤0.01% 986
2016
Q2 		$210K Buy
12,187
+11,127
+1,050% +$347K ﹤0.01% 1002
2016
Q1 		$40K Buy
+1,060
New +$42.3K ﹤0.01% 1072

Other funds holding FCSC

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Jacobs Levy Equity Management's FCSC Position: Q2 2017 in Review

Jacobs Levy Equity Management sold out of Fibrocell Science Inc. (FCSC) in Q2 2017, closing a stake of 6,448 shares — an estimated $64K sold.

Jacobs Levy Equity Management first reported a position in FCSC in Q1 2016 and held it in 4 quarters. The position peaked at $210K in Q2 2016. 29 funds tracked by Wall St. Rank hold FCSC as of Q2 2017.

  • Jacobs Levy Equity Management reported no remaining Fibrocell Science Inc. position as of Q2 2017 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 6,448 Fibrocell Science Inc. shares in Q2 2017, an estimated $64K.
  • Jacobs Levy Equity Management first reported a position in Fibrocell Science Inc. in Q1 2016 and held it in 4 quarters.
  • Jacobs Levy Equity Management's Fibrocell Science Inc. position peaked at $210K in Q2 2016.
  • 29 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q2 2017.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2017, filed 14 Aug 2017.